Dysfunctional Uterine Bleeding in Pediatrics Clinical Presentation

  • Author: Germaine L Defendi, MD, MS, FAAP; Chief Editor: Andrea L Zuckerman, MD   more...
 
Updated: Jul 13, 2011
 

History

Patients present with unexpected and often heavy vaginal bleeding. Irregular menstrual periods are common during the first few years after menarche. Because dysfunctional uterine bleeding (DUB) is largely a diagnosis of exclusion, exploring the more common and serious conditions on the Differential diagnosis list is prudent.

Bleeding associated with complications of pregnancy

Consider any woman of reproductive age pregnant until proven otherwise (with a negative pregnancy test result). Frequently, adolescents do not report sexual behavior, and assuming the history may be less than accurate is prudent. Nevertheless, ask the patient about risk factors for pregnancy and about symptoms of pregnancy, including the following:

  • Symptoms of breast tenderness, nausea, urinary frequency, and fatigue
  • Bleeding associated with severe pain or cramping
  • Bleeding associated with the passage of tissue

Coagulation defects

Depending on the population studied, adolescents with acute menorrhagia could have a 20-30% incidence of a coagulation disorder. Von Willebrand disease (VWD), idiopathic thrombocytopenic purpura (ITP), and leukemia are the more common etiologies. Focus questioning on the following:

  • Family history of bleeding disorders
  • Excessive bleeding associated with minor injuries (eg, small cuts, dental procedures), phlebotomy, or their first period
  • Frequent or prolonged nose bleeds
  • Easy bruising, purpura, or petechiae

Bleeding from an anatomic cause

Anatomic causes of abnormal bleeding can occur anywhere along the female genital tract. Survey the entire organ system with a systematic series of questions, including the following:

  • Recent traumatic intercourse
  • History of sexually transmitted infections, abnormal discharge, or pelvic pain
  • Change in abdominal girth as concern for an intraabdominal or pelvic mass

Medication-related DUB

Obtain a complete history of recent medication use. Specific medications to look for include use of hormonal contraceptive methods, anticoagulants, aspirin, or nonsteroidal anti-inflammatory drugs (NSAIDs).

Polycystic ovarian syndrome (PCOS)

PCOS, an endocrine disorder of hyperandrogenism, is a common cause of anovulation and oligomenorrhea and should always be considered in the differential diagnosis. Some of the physical manifestations of this syndrome (usually due to elevated androgen levels) can be avoided if the diagnosis is made and treatment is begun at an early stage. Common symptoms include the following:

  • Irregular periods
  • Male-pattern hair growth and/or acne
  • Excessive body weight
  • Infertility

Systemic disease

These disease states often cause abnormal bleeding through their impact on the HPO axis. Ask the patient about typical symptoms of endocrine disorders such as diabetes or thyroid disease (hypo- or hyperthyroidism). Additionally, questions aimed at discovering history suggestive of an eating disorder to help explain menstrual cycle dysfunction.

Next

Physical

As in the history, focus the physical examination on uncovering signs of the more common or serious items on the Differential diagnosis list.

General physical examination

A complete examination is always important. Measure height and weight and calculate body mass index (BMI) with age percentile. Pay special attention to the following:

  • Inadequate or excessive weight gain
  • Physical signs of a bleeding dyscrasia (ie, petechiae or purpura)
  • Physical signs of anemia (ie, pale conjunctiva, pale coloring to the skin and/or nail beds, tachycardia)
  • Signs of androgen excess such as acne and/or hirsutism, male-pattern baldness
  • Thyroid enlargement
  • Tanner breast stage and evidence of nipple discharge such as galactorrhea (suggestive of hyperprolactinemia)
  • A palpable abdominal mass, liver enlargement, and/or splenic enlargement

Pelvic examination

Perform pelvic examination with careful consideration of the patient's age, sexual history, and use of tampons. Make every effort to make this portion of the examination as comfortable and atraumatic as possible. Considerable psychological damage can result from an examination that is performed in a rushed and insensitive manner. If the practitioner is inexperienced in adolescent pelvic examinations, a review of the proper techniques is in order. If the patient is not sexually active, the bimanual examination may be more comfortable when performed using a single, well-lubricated finger in the rectum rather than in the vagina. Most significant pelvic pathology can be felt in this manner.

  • Tanner stage and distribution of pubic hair
  • Discharge and excoriations suggesting chronic vaginal candidiasis
  • Old or acute vulvar and vaginal lacerations and condition of hymnal ring
  • Retained foreign bodies (eg, toilet tissue, tampons, or tampon fragments), as these occasionally cause a chronic blood-tinged vaginal discharge
  • Microscopic examination of the vaginal discharge, cervical cultures or amplified DNA probe on urine samples for Neisseria gonorrhoeae and Chlamydiatrachomatis infection, and Papanicolaou test (Pap smear) if indicated by sexual history
  • Evidence of cervical lesions, cervical motion tenderness, or an open cervical os
  • Uterine size and any pelvic masses or tenderness
Previous
Next

Causes

Anovulation can result from dysfunction in any compartment of the HPO axis. In the pediatric age group, the vast majority of cases can be attributed to an immature axis with acyclic hormonal stimulation of the endometrium. Although anovulatory bleeding can occur in any reproductive-aged female, the following patients may be at greater risk for DUB:

  • Adolescents during the first 3-5 years after menarche
  • Patients with eating disorders (eg, anorexia nervosa, bulimia)
  • Adolescents with a BMI higher than 30 (>95% for age)
  • Morbidly obese women
  • Adolescents under significant psychological stress
  • Athletes under significant exercise stress[8]
Previous
 
 
Contributor Information and Disclosures
Author

Germaine L Defendi, MD, MS, FAAP  Associate Clinical Professor, Department of Pediatrics, Olive View-UCLA Medical Center

Germaine L Defendi, MD, MS, FAAP is a member of the following medical societies: American Academy of Pediatrics

Disclosure: Nothing to disclose.

Specialty Editor Board

Elizabeth Alderman, MD  Director of Fellowship Training Program, Director of Adolescent Ambulatory Service, Professor of Clinical Pediatrics, Department of Pediatrics, Division of Adolescent Medicine, Albert Einstein College of Medicine and Children's Hospital at Montefiore

Elizabeth Alderman, MD is a member of the following medical societies: American Academy of Pediatrics, American Pediatric Society, North American Society for Pediatric and Adolescent Gynecology, and Society for Adolescent Medicine

Disclosure: Merck Honoraria Speaking and teaching

Mary L Windle, PharmD  Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Wayne Wolfram, MD, MPH  Associate Professor, Department of Emergency Medicine, Mercy St Vincent Medical Center

Wayne Wolfram, MD, MPH is a member of the following medical societies: American Academy of Emergency Medicine, American Academy of Pediatrics, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Paul D Petry, DO, FACOP, FAAP  Consulting Staff, Freeman Pediatric Care, Freeman Health System

Paul D Petry, DO, FACOP, FAAP is a member of the following medical societies: American Academy of Osteopathy, American Academy of Pediatrics, American College of Osteopathic Pediatricians, and American Osteopathic Association

Disclosure: Nothing to disclose.

Chief Editor

Andrea L Zuckerman, MD  Assistant Professor of Obstetrics/Gynecology and Pediatrics, Tufts University School of Medicine; Division Director, Pediatric and Adolescent Gynecology, Tufts Medical Center

Andrea L Zuckerman, MD is a member of the following medical societies: American College of Obstetricians and Gynecologists, Association of Professors of Gynecology and Obstetrics, Massachusetts Medical Society, North American Society for Pediatric and Adolescent Gynecology, and Society for Adolescent Medicine

Disclosure: Nothing to disclose.

Additional Contributors

The authors and editors of Medscape Reference gratefully acknowledge the contributions of previous authors Tod C Aeby, MD, and LeighAnn C Frattarelli, MD, MPH,to the development and writing of this article.

References
  1. Bravender T, Emans SJ. Menstrual disorders. Dysfunctional uterine bleeding. Pediatr Clin North Am. Jun 1999;46(3):545-53, viii. [Medline].

  2. Coupey SM, Ahlstrom P. Common menstrual disorders. Pediatr Clin North Am. Jun 1989;36(3):551-71. [Medline].

  3. Lavin C. Dysfunctional uterine bleeding in adolescents. Curr Opin Pediatr. Aug 1996;8(4):328-32. [Medline].

  4. Minjarez DA, Bradshaw KD. Abnormal uterine bleeding in adolescents. Obstet Gynecol Clin North Am. Mar 2000;27(1):63-78. [Medline].

  5. Strickland J, Gibson EJ, Levine SB. Dysfunctional uterine bleeding in adolescents. J Pediatr Adolesc Gynecol. Feb 2006;19(1):49-51. [Medline].

  6. Collins J, Crosignani PG. Endometrial bleeding. Hum Reprod Update. Sep-Oct 2007;13(5):421-31. [Medline].

  7. Anderson SE, Must A. Interpreting the continued decline in the average age at menarche: results from two nationally representative surveys of U.S. girls studied 10 years apart. J Pediatr. Dec 2005;147(6):753-60. [Medline].

  8. Austin SB, Ziyadeh NJ, Vohra S, Forman S, Gordon CM, Prokop LA. Irregular menses linked to vomiting in a nonclinical sample: findings from the National Eating Disorders Screening Program in high schools. J Adolesc Health. May 2008;42(5):450-7. [Medline].

  9. Toth M, Patton DL, Esquenazi B, Shevchuk M, Thaler H, Divon M. Association between Chlamydia trachomatis and abnormal uterine bleeding. Am J Reprod Immunol. May 2007;57(5):361-6. [Medline].

  10. National Heart Lung and Blood Institute (NHLBI). The Diagnosis, Evaluation and Management of von Willebrand Disease -- 2008 Clinical Practice Guidelines. National Institutes of Health. 2008;[Full Text].

  11. [Guideline] ACOG. Management of Anovulatory Bleeding. 2008 Compendium of Selected Publications. 2000;14:1049-56. [Full Text].

  12. Casablanca Y. Management of dysfunctional uterine bleeding. Obstet Gynecol Clin North Am. Jun 2008;35(2):219-34, viii. [Medline].

  13. Stabinsky SA, Einstein M, Breen JL. Modern treatments of menorrhagia attributable to dysfunctional uterine bleeding. Obstet Gynecol Surv. Jan 1999;54(1):61-72. [Medline].

  14. Rajput R, Dhuan J, Agarwal S, Gahlaut PS. Central venous sinus thrombosis in a young woman taking norethindrone acetate for dysfunctional uterine bleeding: case report and review of literature. J Obstet Gynaecol Can. Aug 2008;30(8):680-3. [Medline].

  15. Gultekin M, Diribas K, Buru E, Gökçeoglu MA. Role of a non-hormonal oral anti-fibrinolytic hemostatic agent (tranexamic acid) for management of patients with dysfunctional uterine bleeding. Clin Exp Obstet Gynecol. 2009;36(3):163-5. [Medline].

Previous
Next
 
The menstrual cycle.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.